HOME >> BIOLOGY >> NEWS
Polymer expert writes text about better, inexpensive ways to create plastic

tive fillers today. Such fillers naturally occur in salts and glasses which are surface reactive inorganic compounds. When such compounds are combined with collagen, they can bond with human bones and teeth.

"Bioactive fillers can accelerate bone growth and repair bone defects in dental, craniofacial and orthopedic applications," added Xanthos. Among those compounds we use for this purpose is calcium phosphate which has structural similarity to the mineral phase of the bone. "You cannot easily recognize a polymer (or plastic) that contains fillers," said Xanthos. "But consumers use them daily. For example, look under your car hood. Fillers exist near almost any part of your engine. That's because filled plastics in some cases are better to use than metals. Near a car engine, for example, fillers can increase heat stability and retain certain properties of plastic parts while remaining at elevated temperatures." Working chemists and engineers view this text as an excellent consumer's guide. Listed information includes not only data about the chemical properties of the filler--when applicable its density, moisture and thermal properties--but also practical information such as suppliers, costs and even availability. There's also significant research about identifying new markets and applications for fillers.

Xanthos wrote six of the chapters and called upon international experts to supply the rest of the information.

Xanthos directed the Polymer Engineering Center at NJIT until 2003. Xanthos studied chemical engineering at the University of Toronto, where he received his doctorate in 1974. He has been Manager of Research and Development and Technical services at Marietta Resources International Ltd. and taught at the Stevens Institute of Technology, Hoboken.

Since 1988, Xanthos has been director of research at the Polymer Processing Institute (PPI), an independent non-profit research organization located at NJIT.
'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
19-May-2005


Page: 1 2 3

Related biology news :

1. Polymers show promise for gene delivery, tissue scaffolds, other biomedical applications
2. Polymer aids in blood clotting, pointing way to new treatment
3. Polymer gel can block toxic leakage problem in gene therapy
4. Polymers with copper show promise for implanted sensors
5. UC experts detail new standard for cleaner transportation fuels
6. Changing climate will challenge Northeast agriculture, CU expert warns
7. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
8. Neuroblastoma expert reviews progress and challenges in fighting difficult pediatric cancer
9. Methodist, University of Houston, Cornell combine biomedical imaging expertise
10. Human ancestors learned to walk upright in the trees, say experts
11. Antarctic lake experts to gather June 6, 7 in Montana

Post Your Comments:
(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: